Literature DB >> 12917630

Phosphorylation at serine 28 and acetylation at lysine 9 of histone H3 induced by trichostatin A.

Shuping Zhong1, Hidemasa Goto, Masaki Inagaki, Zigang Dong.   

Abstract

Trichostatin A (TSA), a histone deacetylase inhibitor, strongly increases acetylation of the N-terminal tails of histone H3. Many studies have correlated the function of TSA with the hyperacetylation of histone. Although histone H3 is known to be phosphorylated, the effect of acetylation on phosphorylation is not known. Here, we report that in JB6 cells, TSA induces both acetylation at lysine 9 and phosphorylation at serine 28 of histone H3. UVB irradiation, which is known to induce phosphorylation at serine 28, did not significantly affect phosphorylation of histone H3 in TSA-pretreated JB6 cells. In contrast, TSA markedly increased phosphorylation and acetylation of histone H3 in UVB-pretreated JB6 cells. TSA strongly activated MAP kinases. Moreover, PD98059 and SB202190 inhibited TSA-induced phosphorylation but not acetylation of histone H3. Dominant negative mutant ERK2 and dominant negative mutant p38 kinase blocked TSA-stimulated phosphorylation of histone H3 at serine 28. The results indicate that TSA-induced phosphorylation of histone H3 at serine 28 occurs through activation of the MAP kinase pathway and phosphorylated histone H3 is more sensitive to TSA-induced hyperacetylation. The facilitation of phosphorylation and acetylation of histone H3 induced by TSA may play a critical regulatory role in chromatin remodeling and gene expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917630     DOI: 10.1038/sj.onc.1206507

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  Epigenetic Activation of μ-Opioid Receptor Gene via Increased Expression and Function of Mitogen- and Stress-Activated Protein Kinase 1.

Authors:  Yadav Wagley; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  Mol Pharmacol       Date:  2017-02-02       Impact factor: 4.436

2.  Chromosomal position effects on AAV-mediated gene targeting.

Authors:  Anda M Cornea; David W Russell
Journal:  Nucleic Acids Res       Date:  2010-02-25       Impact factor: 16.971

Review 3.  The inflammatory effect of epigenetic factors and modifications in type 2 diabetes.

Authors:  Mohamad Akbari; Vahideh Hassan-Zadeh
Journal:  Inflammopharmacology       Date:  2019-11-09       Impact factor: 4.473

Review 4.  Histone phosphorylation: a chromatin modification involved in diverse nuclear events.

Authors:  Dorine Rossetto; Nikita Avvakumov; Jacques Côté
Journal:  Epigenetics       Date:  2012-09-04       Impact factor: 4.528

5.  Abnormal expression of TFIIIB subunits and RNA Pol III genes is associated with hepatocellular carcinoma.

Authors:  Junxia Lei; Songlin Chen; Shuping Zhong
Journal:  Liver Res       Date:  2017-09-09

Review 6.  Human endometrial cytodifferentiation by histone deacetylase inhibitors.

Authors:  Hiroshi Uchida; Tetsuo Maruyama; Takashi Nagashima; Masanori Ono; Hirotaka Masuda; Toru Arase; Ikuko Sugiura; Maki Onouchi; Takashi Kajitani; Hironori Asada; Yasunori Yoshimura
Journal:  Hum Cell       Date:  2006-02       Impact factor: 4.174

7.  Signaling cascades triggered by bacterial metabolic end products during reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  T L Morris; R R Arnold; J Webster-Cyriaque
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

Review 8.  Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration.

Authors:  Matthew Neal; Jason R Richardson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-11-04       Impact factor: 5.187

9.  Role of phosphorylated histone H3 serine 10 in DEN-induced deregulation of Pol III genes and cell proliferation and transformation.

Authors:  Qian Zhong; Ganggang Shi; Qingsong Zhang; Yanmei Zhang; Daniel Levy; Shuping Zhong
Journal:  Carcinogenesis       Date:  2013-06-17       Impact factor: 4.944

10.  Lysophosphatidic acid protects cancer cells from histone deacetylase (HDAC) inhibitor-induced apoptosis through activation of HDAC.

Authors:  Ganchimeg Ishdorj; Bonnie A Graham; Xiaojie Hu; Jing Chen; James B Johnston; Xianjun Fang; Spencer B Gibson
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.